Is the pharma market, which is currently at INR2.17 lakh crore (USD25.8 billion), getting too crowded? While some industry experts believe a few clear signs of fatigue have emerged, many say it is not a doom scenario yet and a rebound may not be far.
Related Posts
Remembering Novartis’ Ranjit Shahani: The pharma titan who walked a tightrope for India
Ranjit Shahani, former chief of Novartis Synopsis Ranjit Shahani will be remembered for his astute leadership and trademark calmness amid…
Say cheese! A drug to regrow teeth is in clinical trials
Japanese researchers are soon embarking on human clinical trials for a medicine that will help regrow teeth.
A change of heart: inside a cardiac transplant — despair, doctor, donor, and a new life
Bhikaji Nirgun (on wheelchair), who underwent a heart transplant with Pravin Kulkarni (extreme left), the lead heart transplant surgeon at…